[go: up one dir, main page]

AU2001244614A1 - Oily compositions containing highly fat-soluble drugs - Google Patents

Oily compositions containing highly fat-soluble drugs

Info

Publication number
AU2001244614A1
AU2001244614A1 AU2001244614A AU4461401A AU2001244614A1 AU 2001244614 A1 AU2001244614 A1 AU 2001244614A1 AU 2001244614 A AU2001244614 A AU 2001244614A AU 4461401 A AU4461401 A AU 4461401A AU 2001244614 A1 AU2001244614 A1 AU 2001244614A1
Authority
AU
Australia
Prior art keywords
compositions containing
soluble drugs
containing highly
oily compositions
highly fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001244614A
Other languages
English (en)
Inventor
Haruki Kinoshita
Yoshitaka Nishihara
Takayoshi Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU2001244614A1 publication Critical patent/AU2001244614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AU2001244614A 2000-04-04 2001-03-29 Oily compositions containing highly fat-soluble drugs Abandoned AU2001244614A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000102272 2000-04-04
JP2000-102272 2000-04-04
PCT/JP2001/002621 WO2001074331A1 (fr) 2000-04-04 2001-03-29 Compositions huileuses contenant des medicaments solubles dans des graisses

Publications (1)

Publication Number Publication Date
AU2001244614A1 true AU2001244614A1 (en) 2001-10-15

Family

ID=18616188

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001244614A Abandoned AU2001244614A1 (en) 2000-04-04 2001-03-29 Oily compositions containing highly fat-soluble drugs

Country Status (9)

Country Link
US (1) US20030149061A1 (ja)
EP (1) EP1273287A1 (ja)
JP (1) JP3831253B2 (ja)
KR (1) KR20030009416A (ja)
CN (1) CN1431896A (ja)
AU (1) AU2001244614A1 (ja)
CA (1) CA2404381A1 (ja)
MX (1) MXPA02009763A (ja)
WO (1) WO2001074331A1 (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60335635D1 (de) 2002-05-22 2011-02-17 Amgen Inc Aminopyrimidin-derivate zur verwendung als vanilloid-rezeptor-liganden zur behandlung von schmerzen
EP1717220A3 (en) 2002-08-08 2007-08-22 Amgen, Inc Vanilloid receptor ligands and their use in treatments
US20050282814A1 (en) * 2002-10-03 2005-12-22 Targegen, Inc. Vasculostatic agents and methods of use thereof
JP2005075804A (ja) * 2003-09-03 2005-03-24 Toyo Capsule Kk メナテトレノン含有医薬組成物
IL159729A0 (en) * 2004-01-06 2004-06-20 Doron I Friedman Non-aqueous composition for oral delivery of insoluble bioactive agents
WO2005077938A1 (en) 2004-02-11 2005-08-25 Amgen Inc. Vanilloid receptor ligands and their use in treatments
MY139645A (en) 2004-02-11 2009-10-30 Amgen Inc Vanilloid receptor ligands and their use in treatments
EP2543376A1 (en) 2004-04-08 2013-01-09 Targegen, Inc. Benzotriazine inhibitors of kinases
EP1799656A4 (en) 2004-08-25 2009-09-02 Targegen Inc HETEROCYCLIC COMPOUNDS AND METHODS OF USE
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
CN101155799A (zh) * 2005-03-16 2008-04-02 塔格根公司 嘧啶化合物和使用方法
US20060292203A1 (en) * 2005-06-08 2006-12-28 Targegen, Inc. Methods and compositions for the treatment of ocular disorders
EP1928237A4 (en) 2005-09-02 2011-03-09 Abbott Lab NEW HETEROCYCLES BASED ON IMIDAZO
JP2009513642A (ja) * 2005-10-25 2009-04-02 アボット・ラボラトリーズ 低水溶解度の薬剤を含む製剤およびそれの使用方法
US8604042B2 (en) * 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
NZ567851A (en) * 2005-11-01 2011-09-30 Targegen Inc Bi-aryl meta-pyrimidine inhibitors of kinases
US8133900B2 (en) * 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
WO2007056075A2 (en) * 2005-11-02 2007-05-18 Targegen, Inc. Six membered heteroaromatic inhibitors targeting resistant kinase mutations
CL2007003217A1 (es) * 2006-11-09 2008-07-04 Takeda Pharmaceutical Composicion farmaceutica que comprende 1) (r)-5,6-dimetoxi-2-[2,2,4,6,7-pentametil-3-(4-metil-fenil)-2,3-dihidro-1-benzofuran-5-il]-isoindolina, 2) un componente lipofilico y 3) un agente tensoactivo; y capsula que contiene a dicha composicion farmac
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
MX338680B (es) * 2009-05-11 2016-04-27 Nestec Sa Bifidobacterium longum ncc2705 (cncm i-2618) y padecimientos inmunes.
CA2781685C (en) 2009-12-11 2018-09-04 Autifony Therapeutics Limited Imidazolidinedione derivatives
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
WO2011133920A1 (en) 2010-04-23 2011-10-27 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
PL2649066T3 (pl) 2010-12-06 2017-04-28 Autifony Therapeutics Limited Pochodne hydantoiny przydatne jako inhibitory KV3
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
BR112013031402A2 (pt) 2011-06-07 2017-06-27 Autifony Therapeutics Ltd derivados de hidantoína como inibidores de kv3
US9669030B2 (en) 2012-05-22 2017-06-06 Autifony Therapeutics Limited Hydantoin derivatives as Kv3 inhibitors
EP2852589B1 (en) 2012-05-22 2021-04-28 Autifony Therapeutics Limited Triazoles as kv3 inhibitors
BR122023004130B1 (pt) 2013-06-27 2023-12-12 Pfizer Inc Compostos heteroaromáticos, composição farmacêutica e uso dos referidos compostos no tratamento de distúrbios mediados ou associados a dopamina d1
JP6594635B2 (ja) * 2015-03-19 2019-10-23 日清オイリオグループ株式会社 食用油脂
EP3429578B1 (en) * 2016-03-14 2022-08-10 Team Foods Colombia S.a. Composition and method for treatment of cognitive impairment
WO2020151633A1 (en) * 2019-01-25 2020-07-30 Shenzhen Pharmacin Co., Ltd. Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5329916A (en) * 1976-08-31 1978-03-20 Yamanouchi Pharmaceut Co Ltd Ready absorption oryzanol preparation
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
US5504105A (en) * 1990-03-23 1996-04-02 Chinoin Pharmaceutical And Chemical Works Co. Ltd. Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
WO1994000424A1 (en) * 1992-06-25 1994-01-06 G.D. Searle & Co. Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2948111B2 (ja) * 1994-09-16 1999-09-13 塩野義製薬株式会社 経口投与用油性組成物
CN1101373C (zh) * 1996-04-22 2003-02-12 盐野义制药株式会社 新三联苯化合物以及含有新三联苯化合物的药物
CN1232443A (zh) * 1996-07-31 1999-10-20 盐野义制药株式会社 新的对三联苯化合物
EP0953359A4 (en) * 1996-12-19 2001-12-19 Daiichi Seiyaku Co PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
BR9908539A (pt) * 1998-01-28 2000-12-05 Shionogi & Co Ltda Compostos tricìclicos

Also Published As

Publication number Publication date
MXPA02009763A (es) 2003-03-27
KR20030009416A (ko) 2003-01-29
JP3831253B2 (ja) 2006-10-11
CA2404381A1 (en) 2002-09-26
WO2001074331A1 (fr) 2001-10-11
EP1273287A1 (en) 2003-01-08
CN1431896A (zh) 2003-07-23
US20030149061A1 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
AU2001244614A1 (en) Oily compositions containing highly fat-soluble drugs
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
IL162213A0 (en) Pharmaceutical compositions containing active vitamin d compounds
AU2002313236A1 (en) Medicinal compositions
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
AU2001269508A1 (en) Drugs or cosmetics
AU2002217464A1 (en) Medicinal compositions containing aspirin
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001273919A1 (en) Pharmaceutical compositions
AUPQ761100A0 (en) Lipophilic medicament
AU2002221099A1 (en) Combination drugs
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU4085201A (en) Pharmaceutical composition
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU3586401A (en) Pharmaceutical composition
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001292578A1 (en) Pharmaceutical compounds
AU2002354460A1 (en) Medicinal composition
AU2001282541A1 (en) Medicinal compositions